What is the ticker symbol for Titan Pharmaceuticals?

Titan Pharmaceuticals trades under the ticker TTNP on NASDAQ.

What sector does Titan Pharmaceuticals operate in?

Titan Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze TTNP in a portfolio?

PortView shows TTNP's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Titan Pharmaceuticals (TTNP) Stock Analysis

NASDAQHealthcareBiotechnology

$2.34-11.36%

1-year price historyRange $1.55 – $5.30

52-week range$2.34

$2.33$15.15

What Titan Pharmaceuticals does

Titan Pharmaceuticals, Inc. is a pharmaceutical company dedicated to creating treatments for chronic conditions, with its product development centered around ProNeura, a unique platform designed for extended drug release. Currently, the company markets the Probuphine implant in Canada and the European Union. This implant provides maintenance treatment for clinically stable individuals struggling with opioid use disorder. Beyond Probuphine, Titan Pharmaceuticals is advancing several pipeline candidates. Among these is the kappa opioid agonist peptide program (TP-2021), which utilizes the ProNeura technology to address chronic pruritus. Another key development is a nalmefene implant program, aimed at preventing opioid relapse in patients after detoxification from opioid use disorder. Furthermore, the company is exploring other applications for its ProNeura platform, including a single implant for HIV prevention and a contraceptive option for women and adolescent girls. Established in 1992, Titan Pharmaceuticals operates from its base in South San Francisco, California.

Key metrics

Market cap

$3.11M

P/E (TTM)

-0.80

EPS (TTM)

$-2.92

Beta

1.38

Dividend yield

0.00%

Revenue / share

$2,683.13

50-day avg

$4.38

200-day avg

$4.05

52-week high

$15.15

52-week low

$2.33

CEO

Weei Jye Chay

ETFs linked to TTNP

Broad-market and Healthcare sector ETFs an investor holding Titan Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how TTNP fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze TTNP in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Titan Pharmaceuticals?: Titan Pharmaceuticals trades under the ticker TTNP on NASDAQ.
Which exchange is TTNP listed on?: TTNP is listed on NASDAQ.
What sector does Titan Pharmaceuticals operate in?: Titan Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze TTNP in a portfolio?: PortView shows TTNP's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.